Edit Entry | Edit CV

Florian R Schroeck, MD, MS

Title(s)
Associate Professor of Surgery
Associate Professor of The Dartmouth Institute

Additional Titles/Positions/Affiliations
Section Chief of Urology, White River Jct. VA Medical Center

Department(s)
Surgery
The Dartmouth Institute

Websites
https://tdi.dartmouth.edu/about/our-people/directory/florian-schroeck-md-ms

Academic Analytics
View Profile

Contact Information


Selected Publications

 

Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter, Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During Cancer Surveillance with Xpert Bladder Cancer Monitor or Bladder EpiCheck Urine Testing Versus Frequent Cystoscopy.
Schroeck FR, Grubb R, MacKenzie TA, Ould Ismail AA, Jensen L, Tsongalis GJ, Lotan Y
Eur Urol Open Sci. 2024 May;63:19-30. doi: 10.1016/j.euros.2024.02.018. Epub 2024 Mar 21.
PMID: 38558761

Accurate Documentation Contributes to Guideline-concordant Surveillance of Nonmuscle Invasive Bladder Cancer: A Multisite Department of Veterans Affairs Study.
Lyall V, Ould Ismail AA, Haggstrom DA, Issa MM, Siddiqui MM, Tosoian J, Schroeck FR
Urology. 2023 Nov;181:92-97. doi: 10.1016/j.urology.2023.08.014. Epub 2023 Sep 1.
PMID: 37660946

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification.
Lotan Y, Raman JD, Konety B, Daneshmand S, Schroeck F, Shariat SF, Black P, de Lange M, Asroff S, Goldfischer E, Efros M, Chong KT, Huang E, Chua HL, Wu QH, Yeow S, Lau W, Yong J, Eng M
J Urol. 2023 Apr;209(4):762-772. doi: 10.1097/JU.0000000000003126. Epub 2022 Dec 30.
PMID: 36583640

Data-driven approach to implementation mapping for the selection of implementation strategies: a case example for risk-aligned bladder cancer surveillance.
Schroeck FR, Ould Ismail AA, Haggstrom DA, Sanchez SL, Walker DR, Zubkoff L
Implement Sci. 2022 Sep 1;17(1):58. doi: 10.1186/s13012-022-01231-6. Epub 2022 Sep 1.
PMID: 36050742

Ileal Conduit Versus Continent Urinary Diversion in Radical Cystectomy: A Retrospective Cohort Study of 30-day Complications, Readmissions, and Mortality.
Rezaee ME, Atwater BL, Bihrle W, Schroeck FR, Seigne JD
Urology. 2022 Dec;170:139-145. doi: 10.1016/j.urology.2022.08.020. Epub 2022 Aug 22.
PMID: 36007686

Using electronic health records to streamline provider recruitment for implementation science studies.
Okorie CL, Gatsby E, Schroeck FR, Ould Ismail AA, Lynch KE
PLoS One. 2022;17(5):e0267915. doi: 10.1371/journal.pone.0267915. Epub 2022 May 13.
PMID: 35560153

Context-Based Identification of Muscle Invasion Status in Patients With Bladder Cancer Using Natural Language Processing.
Yang R, Zhu D, Howard LE, De Hoedt A, Schroeck FR, Klaassen Z, Freedland SJ, Williams SB
JCO Clin Cancer Inform. 2022 Jan;6:e2100097. doi: 10.1200/CCI.21.00097.
PMID: 35073149

Urologist practice structure and quality of prostate cancer care.
Modi PK, Yan P, Hollenbeck BK, Kaufman SR, Borza T, Skolarus TA, Schroeck FR, Ryan AM, Shahinian VB, Herrel LA
Urol Pract. 2020 Sep;7(5):419-424. doi: 10.1097/upj.0000000000000123. Epub 2020 Sep 1.
PMID: 34541260

Determinants of Risk-Aligned Bladder Cancer Surveillance-Mixed-Methods Evaluation Using the Tailored Implementation for Chronic Diseases Framework.
Schroeck FR, Ould Ismail AA, Perry GN, Haggstrom DA, Sanchez SL, Walker DR, Young J, Zickmund S, Zubkoff L
JCO Oncol Pract. 2022 Jan;18(1):e152-e162. doi: 10.1200/OP.21.00226. Epub 2021 Aug 31.
PMID: 34464159

Partial Versus Complete Bacillus Calmette-Guerin Intravesical Therapy and Bladder Cancer Outcomes in High-risk Non-muscle-invasive Bladder Cancer: Is NIMBUS the Full Story?
Rezaee ME, Ismail AAO, Okorie CL, Seigne JD, Lynch KE, Schroeck FR
Eur Urol Open Sci. 2021 Apr;26:35-43. doi: 10.1016/j.euros.2021.01.009. Epub 2021 Feb 16.
PMID: 34337506

View more publications on PubMed